Alteration of tight junctions during botulinum toxin type A-inhibited salivary secretion.

Abstract

OBJECTIVES:

Tight junctions (TJs) are involved in the regulation of salivary secretion via paracellular pathway. Botulinum toxin type A (BTXA) is widely used for the treatment of hypersecretion diseases such as sialorrhea. This study aimed to investigate the role of TJs in BTXA-inhibited secretion of the submandibular gland (SMG).

MATERIALS AND METHODS:

BTXA was injected into the SMGs of rats, and the same amount of saline was injected as a control. Western blot, real-time PCR, and immunofluorescence staining were used to detect the expression and distribution of TJ proteins. Paracellular permeability was evaluated using the transepithelial electrical resistance (TER) measurements and fluorescent tracer detection in BTXA-stimulated SMG-C6 cells.

RESULTS:

BTXA injection into the SMGs of rats led to increased expression of claudin (Cldn) -1 and Cldn3. Immunofluorescence staining showed no significant changes in the distribution of TJ proteins. In vitro, BTXA increased the TER values and significantly reduced the permeability of fluorescent tracer, suggesting that BTXA decreased the paracellular permeability. The expression levels of Cldn1, Cldn3, and Cldn4 were upregulated after BTXA treatment.

CONCLUSION:

The expression of TJ proteins changed in both animal models and SMG-C6 cells after BTXA treatment, which may contribute to the inhibition of salivary secretion.

• Authors: Qian-Ying Mao, Shang Xie, Li-Ling Wu, Ruo-Lan Xiang, Zhi-Gang Cai
• Journal: Oral diseases (Oral Dis) Vol. 29 Issue 5 Pg. 2086-2095 (Jul 2023) ISSN: 1601-0825 [Electronic] Denmark
• PMID: 35472254 (Publication Type: Journal Article)
• Copyright: © 2022 Wiley Periodicals LLC.

Chemical References

• Botulinum Toxins, Type A

Topics

• Rats
• Animals
• Tight Junctions (physiology)
• Botulinum Toxins, Type A (pharmacology, metabolism)
• Salivation
• Submandibular Gland (metabolism)